CNS & Neurological Disorders - Drug Targets
Title:Editorial (Thematic Issue:Neuroscience of Exercise: Focus on Cognitive and Brain Functioning)
Volume: 14 Issue: 9
Author(s): Sergio Machado and Antonio Egidio Nardi
Affiliation:
Export Options
About this article
Cite this article as:
Machado Sergio and Nardi Egidio Antonio, Editorial (Thematic Issue:Neuroscience of Exercise: Focus on Cognitive and Brain Functioning), CNS & Neurological Disorders - Drug Targets 2015; 14 (9) . https://dx.doi.org/10.2174/187152731409151127173452
DOI https://dx.doi.org/10.2174/187152731409151127173452 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
28
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
Current Pharmaceutical Design Bradykinin B2 receptors play a neuroprotective role in Hypoxia/reoxygenation injury related to pyroptosis pathway
Current Neurovascular Research Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy Proteasome Modulation in Brain: A New Target for Anti-Aging Drugs?
Central Nervous System Agents in Medicinal Chemistry Characterization of the Early CNS Stress Biomarkers and Profiles Associated with Neuropsychiatric Diseases
Current Genomics Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Survey of NMDA Receptor-related Biomarkers for Depression
Current Pharmaceutical Design Exploring Mode of Phosphoramidon and Aβ Peptide Binding to hECE-1 by Molecular Dynamics and Docking Studies
Protein & Peptide Letters The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) The NR2B Subtype of NMDA Receptor: A Potential Target for the Treatment of Alcohol Dependence
Current Drug Targets - CNS & Neurological Disorders Induction of RhoGAP and Pathological Changes Characteristic of Alzheimers Disease by UAHFEMF Discharge in Rat Brain
Current Alzheimer Research Peptide Mimetics of Neurotrophins and their Receptors
Current Pharmaceutical Design The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review
Current Neuropharmacology The Role of P2X Receptors in Bone Biology
Current Medicinal Chemistry Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer's Disease and Mild Cognitive Impairment
Current Alzheimer Research Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution
Current Medicinal Chemistry In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
Current Pharmaceutical Design Low Activity of Plasminogen Activator: A Common Feature of Non- Iatrogenic Comorbidities of Schizophrenia
CNS & Neurological Disorders - Drug Targets Synthesis of New Cyclic Imides Derived From Safrole, Structure- and Ligand-based Approaches to Evaluate Potential New Multitarget Agents Against Species of Leishmania
Medicinal Chemistry